Baidu
map

Diabetes Care:BMI高合并子痫前期,增加产后T2DM风险

2018-12-08 国际糖尿病编辑部 国际糖尿病

一项最新研究结果表明,体质指数(BMI)高且有妊娠期高血压疾病(HDP,如子痫前期和妊娠期高血压)的女性在产后患2型糖尿病(T2DM)的风险增加。

一项最新研究结果表明,体质指数(BMI)高且有妊娠期高血压疾病(HDP,如子痫前期和妊娠期高血压)的女性在产后患2型糖尿病(T2DM)的风险增加。

瑞典隆德大学Simon Timpka及其同事指出,有HDP病史的女性维持健康体重会有额外获益,因为产后BMI可介导HDP病史与慢性高血压事件之间的关系。然而,有HDP病史的女性保持健康BMI是否比无HDP病史的女性在预防T2DM方面更重要尚不明确。

研究者对护士健康研究Ⅱ中56 159例女性数据进行了分析,平均年龄46.3岁。其中,6563例(11%)女性有HDP病史。受试者于1991~2013年接受随访,完成生育史调查问卷,以确认子痫前期或妊娠高血压情况。研究期间,受试者每2年完成一次调查问卷以确认T2DM诊断

随访期间,1341例女性被诊断为T2DM。无论HDP如何,BMI均与糖尿病风险密切相关。研究者注意到,在正常体重女性中,有HDP病史者比无HDP病史者的T2DM发生风险增加1倍(HR=2.08;95%CI:1.06~4.06)。当受试者同时有较高的BMI和HDP病史时,其与T2DM风险存在额外的交互作用(P=0.004)。

在有HDP病史的女性中,BMI>35 kg/㎡(Ⅱ度肥胖)、30~34.9 kg/㎡(Ⅰ度肥胖)以及25~29.9 kg/㎡(超重)者发生T2DM的相对额外风险分别为14.02(95%CI:2.83~25.22)、10.69(95%CI:3.67~17.7)和0.98(95%CI:-1.92~3.87)。BMI和HDP病史的共同作用对Ⅰ度肥胖(36%;95%CI:13~59)女性比对Ⅱ度肥胖(24%;95%CI:5~42)和超重(12%;95%CI:-22~46)女性的贡献更大。

研究者写道,该研究结果表明,BMI高且有HDP病史的女性患T2DM的风险高于预期。这项研究进一步支持HDP病史是代谢易感性的一种标志,可能在产后几年与BMI协同作用进一步增加T2DM发生风险。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1760929, encodeId=51f91e6092940, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon May 06 13:41:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638897, encodeId=2d43163889e19, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 01 07:41:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902180, encodeId=7a7f190218075, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Oct 30 11:41:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355029, encodeId=7bc535502978, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Dec 10 18:10:21 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366563, encodeId=04f413665633c, content=<a href='/topic/show?id=097a452219b' target=_blank style='color:#2F92EE;'>#子痫前期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45221, encryptionId=097a452219b, topicName=子痫前期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Dec 10 13:41:00 CST 2018, time=2018-12-10, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1760929, encodeId=51f91e6092940, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon May 06 13:41:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638897, encodeId=2d43163889e19, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 01 07:41:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902180, encodeId=7a7f190218075, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Oct 30 11:41:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355029, encodeId=7bc535502978, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Dec 10 18:10:21 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366563, encodeId=04f413665633c, content=<a href='/topic/show?id=097a452219b' target=_blank style='color:#2F92EE;'>#子痫前期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45221, encryptionId=097a452219b, topicName=子痫前期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Dec 10 13:41:00 CST 2018, time=2018-12-10, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1760929, encodeId=51f91e6092940, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon May 06 13:41:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638897, encodeId=2d43163889e19, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 01 07:41:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902180, encodeId=7a7f190218075, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Oct 30 11:41:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355029, encodeId=7bc535502978, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Dec 10 18:10:21 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366563, encodeId=04f413665633c, content=<a href='/topic/show?id=097a452219b' target=_blank style='color:#2F92EE;'>#子痫前期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45221, encryptionId=097a452219b, topicName=子痫前期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Dec 10 13:41:00 CST 2018, time=2018-12-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1760929, encodeId=51f91e6092940, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon May 06 13:41:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638897, encodeId=2d43163889e19, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 01 07:41:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902180, encodeId=7a7f190218075, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Oct 30 11:41:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355029, encodeId=7bc535502978, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Dec 10 18:10:21 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366563, encodeId=04f413665633c, content=<a href='/topic/show?id=097a452219b' target=_blank style='color:#2F92EE;'>#子痫前期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45221, encryptionId=097a452219b, topicName=子痫前期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Dec 10 13:41:00 CST 2018, time=2018-12-10, status=1, ipAttribution=)]
    2018-12-10 orangesking

    看看

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1760929, encodeId=51f91e6092940, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Mon May 06 13:41:00 CST 2019, time=2019-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1638897, encodeId=2d43163889e19, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Mon Apr 01 07:41:00 CST 2019, time=2019-04-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1902180, encodeId=7a7f190218075, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=89, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Wed Oct 30 11:41:00 CST 2019, time=2019-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=355029, encodeId=7bc535502978, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=133, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0aa31415219, createdName=orangesking, createdTime=Mon Dec 10 18:10:21 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1366563, encodeId=04f413665633c, content=<a href='/topic/show?id=097a452219b' target=_blank style='color:#2F92EE;'>#子痫前期#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=92, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45221, encryptionId=097a452219b, topicName=子痫前期)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=52c7237, createdName=yahu, createdTime=Mon Dec 10 13:41:00 CST 2018, time=2018-12-10, status=1, ipAttribution=)]
    2018-12-10 yahu

相关资讯

Lancet Diabetes Endocrinol:BMI与死亡率的“J”型关系:死亡风险很低的BMI是?

2018年10月30日,《Lancet Diabetes Endocrinol》在线发表了一项针对BMI和死亡率的研究,该研究覆盖了英国360多万人,再次验证了BMI与死亡率的“J”型关系。主要结果本研究共纳入了3632674名参与者。研究观察到年龄和BMI的正相关:偏瘦组(BMI<18.5 kg/m2)人群的中位年龄为25岁;正常组(BMI 18.5-24.9 kg/m2)人群的中位年龄为33岁

Circulation:体重指数(BMI)与年轻人的心血管健康也密切相关

一直以来,身体质量指数(BMI)被认为与中年至老年心血管健康相关,但在年轻人中尚未进行过研究,也无详细的心血管表型。基因型重复分析(RbG)是一种能够在较小的研究中收集精确的表型测量数据,同时又能保持统计能力和因果推断的能力的方法。在本研究中,研究人员综合采用传统的多变量回归分析、孟德尔随机化(MR)和亚样本RbG方法来评估BMI对来年轻健康受试者的心血管健康的影响。根据MR和RbG分析,BMI越

Diabetic Med:根据HbA1c,体重和低血糖事件发生率评估1型糖尿病管理维持改善的经济价值

近日,国际杂志 《Diabetic Med》上在线发表一项关于根据HbA 1c,体重和低血糖事件发生率评估1型糖尿病管理保持改善的经济价值的研究。 胰岛素治疗适用于1型糖尿病患者。 然而,与治疗相关的体重增加和低血糖只最佳血糖管理的主要障碍。本研究评估了英国1型糖尿病人群中维持HbA 1c,BMI和低血糖发生率降低的健康经济价值。 Cardiff 1型糖尿病模型用于估计不同基线HbA

Lancet Diabetes Endo:BMI与疾病特异性死亡风险

研究发现BMI与大多数疾病死亡风险呈J相关,而与精神、行为和神经疾病死亡风险呈负相关

NEJM:研究揭示预防肥胖的关键时期

一项大型研究发现,大多数肥胖青少年在2~6岁的儿童早期体重增加最明显,之后体重增加速度减慢但仍在继续增加,导致青少年期肥胖程度更高。

EASD2018丨10岁到成年期之间体质指数变化较大可独立于成年期体重指数与2型糖尿病风险相关

肥胖是2型糖尿病的重要危险因素。年龄、性别、种族差异、不同的体脂分布及遗传因素都可独立于体质指数(BMI)导致2型糖尿病风险的差异

Baidu
map
Baidu
map
Baidu
map